Merial, a Sanofi Aventis company that was created in 1997 when animal health division of Rhone Poulenc and Merck AgVet combined their animal health assets in a 50:50 joint venture. The new company was a stand alone enterprise with the industry’s broadest line of products and services to manage animal health. In 2009 Sanofi bought Merck’s stake and Merial became a wholly owned subsidiary of Sanofi.
At present Merial operates in more than 150 countries with over 6200 employees working to provide a broad range of pharmaceutical products, vaccinations and services that enhance the health and well being of companion animals, production animals and wildlife. It is at the forefront of modern day veterinary medicine with a range of products that is revolutionizing animal care.
Merial offers an extensive line of innovative pharmaceuticals and vaccinations designed especially for dogs, cats, birds, swine, cattle and horses. For companion animals such as cats and dogs, provides products for dogs, cats, birds, swine, cattle and horses. Merial offers industry leading products for flea and tick control as well as vaccines for rabies and parvo – virus, leukemia, heart worm and other feline and canine diseases. It also offers solutions for poultry and pork breeders and keepers.